57.—(1) Subject to paragraphs (2) to (4), the Medicines (Products for Human Use) (Fees) Regulations 2010(1) (“the 2010 Regulations”) are revoked.
(2) The savings introduced by regulation 52(2), (3) and (4) of the 2010 Regulations shall continue to apply as if those paragraphs of that regulation had not been revoked.
(3) The 2010 Regulations shall continue to apply as if they had not been revoked—
(a)in relation to capital fees payable under the 2010 Regulations in respect of any application or inspection made before the date on which these Regulations come into force; and
(b)to any periodic fee payable under the 2010 Regulations in relation to a fee period ending before the date on which these Regulations come into force.
(4) The revocation of the 2010 Regulations shall not affect any proceedings under those Regulations for the recovery of any fees due as debts to the Crown and for the purposes of those proceedings, the 2010 Regulations shall continue to apply as if they had not been revoked.